Solesence (SLSN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for December 18, 2024, at the corporate headquarters in Romeoville, Illinois.
Stockholders will vote on electing two Class III directors and ratifying the appointment of RSM US LLP as independent auditors for 2024.
The record date for voting eligibility is November 22, 2024, with 69,994,979 shares outstanding, each entitled to one vote.
Proxy materials and the annual report are distributed together, with options for electronic delivery to reduce environmental impact.
Voting matters and shareholder proposals
Proposals include electing two Class III directors and ratifying RSM US LLP as auditors.
Board recommends voting FOR both proposals.
Quorum requires a majority of outstanding shares; plurality needed for director election, majority for auditor ratification.
Shareholders can submit proposals for the 2025 meeting by July 30, 2025.
Board of directors and corporate governance
Board consists of four directors divided into three classes with staggered three-year terms.
Nominees: Jess A. Jankowski (President, CEO, CFO) and Mark E. Miller (Director), both with extensive industry and leadership experience.
Other directors: R. Janet Whitmore (Chair) and Laura M. Beres, both with significant financial and strategic backgrounds.
Board committees: Audit and Finance, Compensation, and Nominating and Corporate Governance, each with defined charters.
Board held 21 meetings in 2023; all directors attended except one committee meeting.
Board leadership structure separates Chair and CEO roles; diversity considered in nominations.
Directors encouraged, but not required, to attend annual meetings.
Latest events from Solesence
- Record revenue, margin gains, and Nasdaq uplisting plans highlight robust growth outlook.SLSN
Q4 20243 Feb 2026 - Record Q2 revenue and profit, with Solésence driving 44% year-over-year growth.SLSN
Q2 20242 Feb 2026 - Record Q3 revenue, profit, and margin gains fueled by Solésence's exceptional growth.SLSN
Q3 202417 Jan 2026 - Annual meeting to elect directors, approve new equity plan, and ratify auditor, with Board support.SLSN
Proxy Filing2 Dec 2025 - Q1 revenue up 48% to $14.6M; margins fell on launch costs but recovery is expected.SLSN
Q1 202524 Nov 2025 - Q3 revenue dropped 14%, but strategic changes and strong brands support future growth.SLSN
Q3 202517 Nov 2025 - Q2 2025 revenue up 56% to $20.4M, net income and borrowing capacity significantly increased.SLSN
Q2 202516 Nov 2025